Rahul Lakshmanan

Dr. Rahul Lakshmanan

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2017 in Brain
Verified
Journal Article
Open access
PDF file
DLDavid S. Lynch
David S. Lynch
APAnderson Rodrigues Brandão de Paiva
Anderson Rodrigues Brandão de Paiva
WZWei Jia Zhang
Wei Jia Zhang
Enrico BugiardiniEnrico Bugiardini
Enrico Bugiardini
FFFernando Freua
Fernando Freua
HHHenry Houlden
Henry Houlden
Leukodystrophies and genetic leukoencephalopathies are a rare group of disorders leading to progressive degeneration of cerebral white matter. They are associated with a spectrum of clinical phenotypes dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs. Mutations in at least 60 genes can lead to leukoencephalopathy with often overlapping clinical and radiological presentations. For these reasons, patients with genetic leukoencephalopathies often endure a long diagnostic odyssey before receiving a definitive diagnosis or may receive no diagnosis at all. In this study, we used focused and whole exome sequencing to evaluate a cohort of undiagnosed adult patients referred to a specialist leukoencephalopathy service. In total, 100 patients were evaluated using focused exome sequencing of 6100 genes. We detected pathogenic or likely pathogenic variants in 26 cases. The most frequently mutated genes were NOTCH3, EIF2B5, AARS2 and CSF1R. We then carried out whole exome sequencing on the remaining negative cases including four family trios, but could not identify any further potentially disease-causing mutations, confirming the equivalence of focused and whole exome sequencing in the diagnosis of genetic leukoencephalopathies. Here we provide an overview of the clinical and genetic features of these disorders in adults.

1 December 2016 in JAMA Neurology
Verified
Journal Article
Closed access
PDF file
DLDavid S. Lynch
David S. Lynch
WZWei Jia Zhang
Wei Jia Zhang
RLRahul Lakshmanan
Rahul Lakshmanan
JKJustin A. Kinsella
Justin A. Kinsella
GUGünes Altiokka Uzun
Günes Altiokka Uzun
HHHenry Houlden
Henry Houlden
This case series describes the features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia and performs genetic sequencing in patients

1 April 2017 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
RLRahul Lakshmanan
Rahul Lakshmanan
MAMatthew E. Adams
Matthew E. Adams
DLDavid S. Lynch
David S. Lynch
JKJustin A. Kinsella
Justin A. Kinsella
RPRahul Phadke
Rahul Phadke
IDIndran Davagnanam
Indran Davagnanam
Objective: To provide an overview of the phenotype of 2 clinically, radiologically, and pathologically similar leukodystrophies, adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and alanyl-transfer RNA synthetase 2 mutation–related leukodystrophy (AARS2-L), and highlight key differentiating features. Methods: ALSP and AARS2-L cases were identified from the adult-onset leukodystrophy database at our institution. In addition, cases with imaging findings were identified from a literature review. The phenotypic features were determined by combining published cases with those from our database. Results: A combined total of 74 cases of ALSP and 10 cases of AARS2-L with neuroimaging data were identified. The mean age at onset was 42 years in ALSP and 26 years in AARS2-L. Cognitive and motor symptoms were the most common symptoms overall in both. Ovarian failure was exclusive to AARS2-L, present in all known female cases. Both ALSP and AARS2-L showed a confluent, asymmetric, predominantly frontoparietal, periventricular pattern of white matter disease with subcortical U-fiber sparing; pyramidal tract and corpus callosum involvement; and diffusion changes in the white matter which we have termed “deep white matter diffusion dots.” Central atrophy and corpus callosal thinning were prominent in ALSP and disproportionately mild in AARS2-L when present. ALSP also occasionally showed ventricular abnormalities and calcifications in the frontal periventricular white matter, features not seen in AARS2-L. AARS2-L demonstrates white matter rarefaction which suppresses on fluid-attenuated inversion recovery MRI sequences, a feature not seen in ALSP. Conclusions: ALSP and AARS2-L share similar clinical, imaging, and pathologic characteristics with key differentiating features that we have highlighted.

1 December 2018 in Topics in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
FGFabrício G. Gonçalves
Fabrício G. Gonçalves
TFTomás de Andrade L. Freddi
Tomás de Andrade L. Freddi
ATAjay Taranath
Ajay Taranath
RLRahul Lakshmanan
Rahul Lakshmanan
RGRobert Goetti
Robert Goetti
FAFilippo Arrigoni
Filippo Arrigoni
Mutations causing dysfunction of the tubulins and microtubule-associated proteins, otherwise known as tubulinopathies, are a group of recently described entities, that lead to complex brain malformations. An understanding of the fundamental principles of operation of the cytoskeleton and compounds in particular microtubules, actin, and microtubule-associated proteins, can assist in the interpretation of the imaging findings of tubulinopathies. Somewhat consistent morphological imaging patterns have been described in tubulinopathies such as dysmorphic basal ganglia—the hallmark (found in 75% of cases), callosal dysgenesis, cerebellar hypoplasia/dysplasia, and cortical malformations, most notably lissencephaly. Recognizing the common imaging phenotypes present in tubulinopathies can prove invaluable in directing the genetic workup for a patient with brain malformations.

1 June 2017 in Journal of the American Academy of Audiology
Verified
Journal Article
Closed access
PDF file
NKNehzat Koohi
Nehzat Koohi
DVDeborah A. Vickers
Deborah A. Vickers
RLRahul Lakshmanan
Rahul Lakshmanan
HCHoskote Chandrashekar
Hoskote Chandrashekar
DWDavid J. Werring
David J. Werring
DBDoris-Eva Bamiou
Doris-Eva Bamiou
Background:Stroke survivors may suffer from a range of hearing impairments that may restrict their participation in postacute rehabilitation programs. Hearing impairment may have a significant impact on listening, linguistic skills, and overall communication of the affected stroke patient. However, no studies sought to systematically characterize auditory function of stroke patients in detail, to establish the different types of hearing impairments in this cohort of patients. Such information would be clinically useful in understanding and addressing the hearing needs of stroke survivors.Purpose:The present study aimed to characterize and classify the hearing impairments, using a detailed audiological assessment test battery, in order to determine the level of clinical need and inform appropriate rehabilitation for this patient population.Research Design:A case‐control study.Study Sample:Forty-two recruited stroke patients who were discharged from a stroke unit and 40 control participants matched for age.Data Collection and Analysis:All participants underwent pure-tone audiometry and immittance measurements including acoustic reflex threshold, transient-evoked otoacoustic emissions, auditory-evoked brainstem response, and a central auditory processing assessment battery, performed in a single session. Hearing impairments were classified as peripheral hearing loss (cochlear and neural type), central auditory processing disorder (CAPD), and as a combination of CAPD and peripheral hearing loss.Results:Overall mean hearing thresholds were not significantly different between the control and stroke groups. The most common type of hearing impairment in stroke patients was the combination type, “peripheral and CAPD,” in the 61- to 80-yr-old subgroup (in 55%), and auditory processing deficits in 18- to 60-yr-olds (in 40%), which were both significantly higher than in controls.Conclusions:This is the first study to examine hearing function in detail in stroke patients. Given the importance of hearing for the efficiency of communication, it is essential to identify hearing impairments and differentiate peripheral and central deficits to define an appropriate intervention plan.

1 December 2017 in Otology & Neurotology
Verified
Journal Article
Closed access
PDF file
FDFelice D’arco
Felice D’arco
GTGiacomo Talenti
Giacomo Talenti
RLRahul Lakshmanan
Rahul Lakshmanan
KSKate Stephenson
Kate Stephenson
ASAta Siddiqui
Ata Siddiqui
OCOlivia Carney
Olivia Carney
Objective: We conducted an extensive review of the literature relevant to inner ear measurements in normal and malformative conditions to select reproducible methods and normative ranges that may be used in clinical practice. Data Sources and Study Selection: A review of the published literature was performed in the English language using PubMed with appropriate keywords. We selected only those articles containing normative values of inner ear structures. Data Extraction and Data Synthesis: The following measurements were identified as reproducible and sensitive for the diagnosis of inner malformations: cochlear height in coronal plane; maximal diameter of bony island of lateral semicircular canal; width of vestibular aqueduct: 1) at midpoint; 2) at operculum in axial plane; cochlear canal and cochlear width in multiplanar reconstructions (MPR)/axial; cochlear length. The following cutoffs for normal inner ears are proposed based on the comparative analysis of the literature: cochlea height: >4.3 mm; lateral semicircular canal bony island: >3 mm; vestibular aqueduct: <0.9 (midpoint) and 1.4 mm and 5.4 mm. Conclusion: Measurements of inner ear structures can help in the interpretation of computed tomography images. They increase the sensitivity in detecting inner ear malformations, especially cochlear hypoplasia now considered more common than previously thought.